Accueil / Tag Archives: Pharmaceutical

Tag Archives: Pharmaceutical

Baxter and COSMED Announce Partnership to Bring Next-generation Indirect Calorimetry Device, Q-NRG+, to Support Clinical Nutrition Globally

Thursday, August 15th 2019 at 12:34pm UTC Non-invasive metabolic monitor accurately measures patient energy expenditure Designed to help clinicians optimize nutrition therapy in support of improved patient outcomes Portable and flexible design can be used with intubated and spontaneously breathing patients DEERFIELD, Ill. & ROME–(BUSINESS WIRE)– Baxter International Inc. (NYSE: …

Plus »

AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

Wednesday, August 14th 2019 at 9:16pm UTC Moves into new San Francisco Bay Area R&D facility, comprising approximately 15,700-square-feet of office and lab space, including cGMP-capable manufacturing suite. Strengthens leadership at Board level by appointment of regenerative medicine leader Dr. Michael H. May, CEO of Canada’s Centre for Commercialization of …

Plus »

Accellix Announces the Appointment of Charles Piazza to its Board of Directors

Wednesday, August 14th 2019 at 12:00pm UTC SAN JOSE, Calif.–(BUSINESS WIRE)– Accellix Inc. announces the appointment of a new Board Member, Mr. Charles Piazza. Charles (Chuck) Piazza, Accellix’s newest board member, has over 35 years of global experience within the life science industry serving the pharmaceutical, biotechnology and medical research …

Plus »

CALQUENCE® (acalabrutinib) Granted US Breakthrough Therapy Designation for Chronic Lymphocytic Leukemia

Wednesday, August 14th 2019 at 12:00pm UTC Designation based on positive results from two Phase III trials WILMINGTON, Del.–(BUSINESS WIRE)– AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for CALQUENCE® (acalabrutinib) as a monotherapy treatment for adult patients with chronic lymphocytic …

Plus »

Complexa Names Theodore Danoff, MD, PhD, Chief Medical Officer

Monday, August 19th 2019 at 11:00am UTC Experienced industry leader to head Complexa’s clinical development programs BERWYN, Pa.–(BUSINESS WIRE)– Complexa Inc. today announced the appointment of Theodore (Theo) Danoff, MD, PhD, as Chief Medical Officer. Dr. Danoff formerly served as Chief Medical Officer and Senior Vice President, Clinical and Medical …

Plus »

Alfasigma USA Announces ZELNORM™ (tegaserod) Now Available for Treatment of Irritable Bowel Syndrome with Constipation

Thursday, August 15th 2019 at 5:51pm UTC ZELNORM approved by FDA in March 2019 after thorough safety review Alfasigma USA has begun national reintroduction of ZELNORM to prescribers ZELNORM now widely available through wholesale channels and retail pharmacy orders BEDMINSTER, N.J.–(BUSINESS WIRE)– Alfasigma USA, Inc. today announced that ZELNORM™ (tegaserod) …

Plus »

Juvenescence Closes $100 Million Series B Round, Plans Follow on and Incremental Investments in Longevity Drug Development

Monday, August 19th 2019 at 6:00am UTC TORTOLA, British Virgin Islands–(BUSINESS WIRE)– Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to increase human longevity, is pleased to announce the successful closure of its $100 …

Plus »

FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors

Thursday, August 15th 2019 at 8:10pm UTC – First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain – – Genentech’s first FDA-approved tumor-agnostic medicine – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Genentech, a member of the Roche Group …

Plus »

U.S. FDA Approves INREBIC® (Fedratinib) as First New Treatment in Nearly a Decade for Patients With Myelofibrosis

Friday, August 16th 2019 at 2:30pm UTC INREBIC provides new, once-daily oral option for patients affected by rare bone marrow cancer SUMMIT, N.J.–(BUSINESS WIRE)– class= »bwalignl »> Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) has approved INREBIC® (fedratinib) for the treatment of adult patients with intermediate-2 …

Plus »

Sunovion Receives 2018 Corporate Responsibility and Leadership Awards from United Way of Tri-County and Expands Partnership For 8th Annual Community Service Program

Wednesday, August 14th 2019 at 12:00pm UTC MARLBOROUGH, Mass.–(BUSINESS WIRE)– Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the Company has received the 2018 Corporate Responsibility Award and 2018 Corporate Leadership Award from United Way of Tri-County for its positive impact in community service while fostering a culture of Corporate Social …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.